Total Payments
$3,005
2024 Payments
$1,039
Companies
12
Transactions
140
Medicare Patients
2,247
Medicare Billing
$253,317
Payment Breakdown by Category
Food & Beverage$2,699 (89.8%)
Education$306.44 (10.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,699 | 137 | 89.8% |
| Education | $306.44 | 3 | 10.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $735.80 | 23 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $638.23 | 29 | $0 (2024) |
| ABBVIE INC. | $484.10 | 29 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $302.73 | 18 | $0 (2024) |
| Alkermes, Inc. | $254.08 | 12 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $210.73 | 11 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $133.49 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $115.17 | 7 | $0 (2024) |
| ITI, Inc. | $45.52 | 3 | $0 (2023) |
| Corium, LLC | $36.44 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,039 | 57 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($302.73) |
| 2023 | $1,951 | 82 | Janssen Pharmaceuticals, Inc ($735.80) |
| 2021 | $15.14 | 1 | ACADIA Pharmaceuticals Inc ($15.14) |
All Payment Transactions
140 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: PSYCHIATRY | ||||||
| 10/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Central Nervous System | ||||||
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $92.26 | General |
| Category: PSYCHIATRY | ||||||
| 09/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.10 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Neuropsychiatry | ||||||
| 09/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Neurology | ||||||
| 08/29/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: PSYCHIATRY | ||||||
| 08/27/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Neuropsychiatry | ||||||
| 08/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Central Nervous System | ||||||
| 08/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: PSYCHIATRY | ||||||
| 08/01/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: CNS | ||||||
| 07/24/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Central Nervous System | ||||||
| 07/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: CNS | ||||||
| 07/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Neuropsychiatry | ||||||
| 07/11/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: PSYCHIATRY | ||||||
| 07/08/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.62 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 73 | 157 | $15,924 | $6,946 |
| 2022 | 4 | 1,035 | 1,981 | $400,300 | $119,346 |
| 2021 | 5 | 958 | 1,639 | $354,255 | $110,642 |
| 2020 | 3 | 181 | 264 | $54,312 | $16,383 |
Total Patients
2,247
Total Services
4,041
Medicare Billing
$253,317
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Facility | 2023 | 37 | 84 | $9,179 | $4,546 | 49.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 24 | 24 | $5,520 | $2,014 | 36.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Facility | 2023 | 12 | 49 | $1,225 | $384.99 | 31.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 411 | 1,027 | $164,320 | $44,613 | 27.2% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 306 | 630 | $132,300 | $37,361 | 28.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 292 | 295 | $94,400 | $34,773 | 36.8% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 26 | 29 | $9,280 | $2,599 | 28.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 297 | 301 | $96,320 | $36,202 | 37.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 182 | 421 | $67,360 | $19,728 | 29.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 136 | 273 | $57,330 | $16,811 | 29.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 138 | 357 | $56,406 | $15,750 | 27.9% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 104 | 184 | $38,272 | $11,033 | 28.8% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2021 | 89 | 89 | $34,087 | $9,838 | 28.9% |
| 99310 | Subsequent nursing facility visit, typically 35 minutes per day | Facility | 2021 | 12 | 14 | $4,480 | $1,279 | 28.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 90 | 138 | $21,804 | $6,581 | 30.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 55 | 90 | $18,720 | $5,644 | 30.1% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Office | 2020 | 36 | 36 | $13,788 | $4,158 | 30.2% |
About Sherry Carter
Sherry Carter is a Registered Nurse healthcare provider based in Winchester, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2020. The National Provider Identifier (NPI) number assigned to this provider is 1336751734.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sherry Carter has received a total of $3,005 in payments from pharmaceutical and medical device companies, with $1,039 received in 2024. These payments were reported across 140 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,699).
As a Medicare-enrolled provider, Carter has provided services to 2,247 Medicare beneficiaries, totaling 4,041 services with total Medicare billing of $253,317. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Registered Nurse
- Other Specialties Psychiatric/Mental Health, Psychiatric/Mental Health
- Location Winchester, VA
- Active Since 08/18/2020
- Last Updated 06/26/2023
- Taxonomy Code 163W00000X
- Entity Type Individual
- NPI Number 1336751734
Products in Payments
- INVEGA SUSTENNA (Drug) $706.06
- VRAYLAR (Drug) $484.10
- CAPLYTA (Drug) $348.25
- Austedo XR (Drug) $239.78
- ARISTADA (Drug) $226.52
- INGREZZA (Drug) $210.73
- NUPLAZID (Drug) $133.49
- AUSTEDO (Drug) $128.62
- ABILIFY MAINTENA (Drug) $81.34
- UZEDY (Drug) $63.38
- Azstarys (Drug) $36.44
- Auvelity (Drug) $35.49
- REXULTI (Drug) $30.23
- SPRAVATO (Drug) $29.74
- VIVITROL (Drug) $18.64
- ABILIFY ASIMTUFII (Drug) $16.78
- Vivitrol (Drug) $8.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Registered Nurse Doctors in Winchester
Scott Seitz, Aprn-Bc, APRN-BC
Registered Nurse — Payments: $28,028
Registered Nurse $28,028
Mary Ford, Crna, CRNA
Registered Nurse — Payments: $23,933
Registered Nurse $23,933
Vanna Altman, Fnp, FNP
Registered Nurse — Payments: $11,243
Registered Nurse $11,243
Kelly Price, Np, NP
Registered Nurse — Payments: $8,505
Registered Nurse $8,505
Jealena Reesor, Aprn, APRN
Registered Nurse — Payments: $7,762
Registered Nurse $7,762
Sara Ballard, Aprn, APRN
Registered Nurse — Payments: $1,791
Registered Nurse $1,791